CoreAge Rx vs Solaya MD
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Solaya MD head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 64 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make Solaya MD a bad call — it's best for readers considering clinician-guided oral or injectable care who first obtain the exact product and complete subscription quote. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | Solaya MD |
|---|---|---|
| Brief Score | 94/100 (A) | 64/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | Current complete quote unconfirmed Oral and injectable formats advertised; exact preparation, supplied quantity and medication-specific price unconfirmed. Provider approval precedes first charge under refund policy. Portal cancellation stops renewals; email requests need 72 hours before billing. Full price detailsSemaglutide offered in oral and injectable formats; exact preparation and complete current quote unknown; no medication-specific public price established |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | Current complete quote unconfirmed Oral and injectable formats advertised; exact preparation and medication-specific price unconfirmed. First-charge refund requires request within 72 hours and prescription not yet sent to pharmacy. Monthly and multi-month limits differ; confirm governing agreement. Full price detailsTirzepatide offered in oral and injectable formats; exact preparation and complete current quote unknown; no medication-specific public price established |
| Coverage | US only; restrictions by state, confirmed at intake | All 50 states advertised, subject to clinician, pharmacy, state-law and treatment eligibility |
| Brand-name access | Not confirmed | Named semaglutide/tirzepatide formats do not establish current branded GLP-1 prescribing availability; confirm the exact product. |
| Oral / sublingual | Injection only | Yes |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
Solaya MD: Public weight page lists oral and injectable options without a complete medication-specific quote. Confirm exact preparation, supply, renewal interval and governing refund terms.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.